Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Seeks To Prevent Drug Name Confusion, While USP Develops Treatment

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Pharmacopeia's new searchable drug database is designed to help consumers and caregivers avoid errors due to look-alike/sound-alike product names

You may also be interested in...

FDA’s Proposed Name Review Pilot Offers Little Reason To Participate

A proposed FDA pilot program that would shift the burden for safety review of proprietary drug names from the agency to industry needs to account for key differences between OTC and Rx products and lacks participation incentives, pharmaceutical researchers say

Pharmacy Leaflets Become Focus For Patient Safety; IoM, FDA Finalize Standards

Producers of consumer medication information leaflets are hoping that FDA provides them with more time to come into compliance with standards for usefulness, even as an Institute of Medicine report is emphasizing the need for quality in the materials

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts